Citation Impact
Citing Papers
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
2014 Standout
Directed evolution of the tryptophan synthase β-subunit for stand-alone function recapitulates allosteric activation
2015 StandoutNobel
Spatial Distribution of Fibrosis Governs Fibrillation Wave Dynamics in the Posterior Left Atrium During Heart Failure
2007
Discovery of a Novel Class of Phosphodiesterase 10A Inhibitors and Identification of Clinical Candidate 2-[4-(1-Methyl-4-pyridin-4-yl-1 H -pyrazol-3-yl)-phenoxymethyl]-quinoline (PF-2545920) for the Treatment of Schizophrenia†Coordinates of the PDE10A crystal structures have been deposited in the Protein Data Bank for compound 1 (3HQW), 2 (3HQY), 3 (3HQW) and 9 (3HR1).
2009
Shock Reduction Using Antitachycardia Pacing for Spontaneous Rapid Ventricular Tachycardia in Patients With Coronary Artery Disease
2001
PhysioBank, PhysioToolkit, and PhysioNet
2000 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Chagas disease
2010 Standout
An efficient synthesis of risperidonevia stille reaction: Antipsychotic, 5-HT2, and dopamine-D2-antagonist
2005
Biatrial multisite mapping of atrial premature complexes triggering onset of atrial fibrillation
2002
Verapamil
1989
Role of AMP-activated protein kinase in mechanism of metformin action
2001 Standout
An Acute Model for Atrial Fibrillation Arising from a Peripheral Atrial Site: Evidence for Primary and Secondary Triggers
2008
Descending control of pain
2002 Standout
Cyclic nucleotide phosphodiesterase (PDE) superfamily: A new target for the development of specific therapeutic agents
2005 Standout
Second-generation antipsychotics and constipation: A review of the literature
2010
Exercise performance and training in patients with implantable cardioverter-defibrillators and coronary heart disease
2001
Exercise Standards for Testing and Training
2013 Standout
Prevention of inappropriate therapy in implantable cardioverter-defibrillators
2004
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Effects of dissociated glucocorticoids on OPG and RANKL in osteoblastic cells
2005
Mechanisms of Actions of Inhaled Anesthetics
2003 Standout
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
A Panel of Cytochrome P450 BM3 Variants to Produce Drug Metabolites and Diversify Lead Compounds
2009 StandoutNobel
A New Equation to Estimate Glomerular Filtration Rate
2009 Standout
Skeletal remodeling in health and disease
2007 Standout
Blink rate in childhood schizophrenia spectrum disorder
1994
Differential actions of typical and atypical antipsychotic drugs on dopamine release in the core and shell of the nucleus accumbens
1996
Distribution and characterization of the [3H]granisetron-labelled 5-HT3 receptor in the human forebrain
1993
Treatment of Atrial Fibrillation by the Ablation of Localized Sources
2012
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Cytosolic calcium transients: Spatial localization and role in drosophila photoreceptor cell function
1994 StandoutNobel
Catheter Ablation of Long‐Lasting Persistent Atrial Fibrillation: Critical Structures for Termination
2005
Autoradiographic localization of dopamine D1 and D2 receptors in rat nucleus accumbens: Resistance to differential rearing conditions
1991 Standout
Intravenous adenosine in the emergency department management of paroxysmal supraventricular tachycardia
1991
Adenosine versus verapamil in the treatment of supraventricular tachycardia: A randomized double-crossover trial
1992
A review of central 5-HT receptors and their function
1999 Standout
Hypertrophic Cardiomyopathy
2002 Standout
Usefulness of QRST time-integral values of 12-lead electrocardiograms in diagnosing healed myocardial infarction complicated by left bundle branch block
1991 StandoutNobel
Accidental astemizole overdose in young children
1991
Autoradiographic distribution of [ 3 H]-(S)-zacopride-labelled 5-HT 3 receptors in human brain
1996
Incidence and Prognosis of Syncope
2002 Standout
Enhanced Detection Criteria in Implantable Cardioverter-Defibrillators to Avoid Inappropriate Therapy
1996
Effect of exercise training in patients with an implantable cardioverter defibrillator
2004
Accumulation of metformin by tissues of the normal and diabetic mouse
1994
Neurocognitive deficit in schizophrenia: A quantitative review of the evidence.
1998 Standout
Reduced levels of 5-HT3 receptor recognition sites in the putamen of patients with Huntington's disease
1993
Management of patients receiving implantable cardiac defibrillator shocks: Recommendations for acute and long-term patient management
2010
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
Catheter Ablation of Paroxysmal Atrial Fibrillation Initiated by Non–Pulmonary Vein Ectopy
2003
Occurrence of ventricular late potentials in patients with active acromegaly
2001
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Updated Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation
2009 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Prolonged electrocardiographic monitoring in patients with syncope
1987
Chemotaxis of newt eosinophils: calcium regulation of chemotactic response
1993
Long-Term Cardiac Outcomes of Treating Chronic Chagas Disease with Benznidazole versus No Treatment
2006
Catheter Ablation for Paroxysmal Atrial Fibrillation
2003
Atrial Fibrillation Originating From Persistent Left Superior Vena Cava
2004
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
The Intrinsic Autonomic Nervous System in Atrial Fibrillation: A Review
2012
Verapamil therapy: A new approach to the pharmacologic treatment of hypertrophic cardiomyopathy: III. Effects of long-term administration
1981
Effect of Nitrous Oxide on Excitatory and Inhibitory Synaptic Transmission in Hippocampal Cultures
1998
Acceleration of the ventricular response during atrial fibrillation in the Wolff-Parkinson-White syndrome after verapamil.
1982
Nuclear Magnetic Resonance Technology for Medical Studies
1984 StandoutScienceNobel
Calcium Channel Blocking Agents in the Treatment of Cardiovascular Disorders. Part I: Basic and Clinical Electrophysiologic Effects
1980
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Early Exposure to Common Anesthetic Agents Causes Widespread Neurodegeneration in the Developing Rat Brain and Persistent Learning Deficits
2003 Standout
Quality of Life in the Antiarrhythmics Versus Implantable Defibrillators Trial
2002
Epicardial Mapping of Chronic Atrial Fibrillation in Patients
2004
Impact of Psychological Factors on the Pathogenesis of Cardiovascular Disease and Implications for Therapy
1999 Standout
Increased Monday Incidence of Life-Threatening Ventricular Arrhythmias
1996
Positron Tomography and Nuclear Magnetic Resonance Imaging
1982 StandoutScienceNobel
Empirical Versus Tested Antitachycardia Pacing in Implantable Cardioverter Defibrillators
1998
Evolution in functional complexity of heart rate dynamics: a measure of cardiac allograft adaptability
1998
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
Hormone-electrolyte interactions in the pathogenesis of lethal cardiac arrhythmias in patients with congestive heart failure: Basis of a new physiologic approach to control of arrhythmia
1986
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Adverse Events With Transvenous Implantable Cardioverter-Defibrillators
1998
Bepridil and cetiedil. Vasodilators which inhibit Ca2+-dependent calmodulin interactions with erythrocyte membranes.
1984 StandoutNobel
Mechanisms of Diabetic Complications
2013 Standout
Enzyme Immobilization: The Quest for Optimum Performance
2007 Standout
Interactions of D600 (methoxyverapamil) and local anesthetics with rat brain α-adrenergic and muscarinic receptors
1980
Serum Creatinine as an Index of Renal Function: New Insights into Old Concepts
1992 Standout
Interaction of calcium antagonists with cyclic AMP phosphodiesterases and calmodulin
1982
Intrinsic Cardiac Nerve Activity and Paroxysmal Atrial Tachyarrhythmia in Ambulatory Dogs
2010
Verapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy.
1981
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2006
Comparative pharmacology of calcium antagonists: Nifedipine, verapamil and diltiazem
1980 Standout
Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors.
2000 StandoutNobel
Left bundle branch block: A continuously evolving concept
1987
Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. I. Hemodynamic effects.
1979
Part 8: Adult Advanced Cardiovascular Life Support
2010 Standout
A Medicinal Chemist’s Guide to Molecular Interactions
2010 Standout
Sodium/Calcium Exchange: Its Physiological Implications
1999 Standout
National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification
2003 Standout
Long term results of cardioverter-defibrillator implantation in patients with right ventricular dysplasia and malignant ventricular tachyarrhythmias
2001
Spectral Analysis Identifies Sites of High-Frequency Activity Maintaining Atrial Fibrillation in Humans
2005
Biocatalytic Synthesis of Chiral Alcohols and Amino Acids for Development of Pharmaceuticals
2013
Assessment of Pharmacological Treatment of Myocardial Infarction by Phosphorus-31 NMR with Surface Coils
1981 Science
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout
A Prospective Evaluation and Follow-up of Patients with Syncope
1983 Standout
Microbial/enzymatic synthesis of chiral intermediates for pharmaceuticals
2002
Local Anesthetics and the Inflammatory Response
2000 Standout
The inhibition of Na-dependent Ca uptake by verapamil in synaptic plasma membrane vesicles
1983
Drug Prescribing in Renal Failure: Dosing Guidelines for Adults.
1988
Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain
2000 Standout
Works of C. Thomas Peter being referenced
Selective Atrionodal Input Ablation for Induction of Proximal Complete Heart Block with Stable Junctional Escape Rhythm in Patients with Uncontrolled Atrial Fibrillation
2003
Discrimination of ventricular tachycardia from sinus tachycardia and atrial fibrillation in a tiered-therapy cardioverter-defibrillator
1994
Simultaneous Biatrial Computerized Mapping During Permanent Atrial Fibrillation in Patients with Organic Heart Disease
2002
The Use of Signal‐Averaged Electrocardiography in Predicting Patients at High Risk for Sudden Death
1990
Electric Potentials from a Persistent Left Superior Vena Cava Draining into Coronary Sinus
1999
Hemodynamic adaptation to orthostatic stress after orthotopic heart transplantation
1996
Ventricular arrhythmias
1990
Verapamil
1978
Vein of Marshall Cannulation for the Analysis of Electrical Activity in Patients With Focal Atrial Fibrillation
2000
Programming of Implantable Cardioverter-Defibrillators on the Basis of the Upper Limit of Vulnerability
1997
The frequency and prognostic significance of electrocardiographic abnormalities in clinically normal individuals
1981